We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+0.65%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$73.9B
AUM Growth
-$2.32B
(-3%)
Cap. Flow
-$2.03B
Cap. Flow
% of AUM
-2.75%
Top 10 Holdings %
Top 10 Hldgs %
22.54%
Holding
3,088
New
92
Increased
1,359
Reduced
1,564
Closed
46
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$60.7M |
| 2 |
Analog Devices
ADI
|
+$46.1M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$37.3M |
| 4 |
Match Group
MTCH
|
+$28.2M |
| 5 |
GXO Logistics
GXO
|
+$19.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$89.3M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$78.9M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$77.4M |
| 4 |
Apple
AAPL
|
+$77M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$70.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.91% |
| 2 | Financials | 14.2% |
| 3 | Healthcare | 13.07% |
| 4 | Consumer Discretionary | 12.09% |
| 5 | Communication Services | 9.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2401
CVR Energy
CVI
$3.13B
| $692K | ﹤0.01% |
41,521
+945
| +2% | +$13.3K |
|
|
MCF
2402
DELISTED
Contango Oil & Gas Co.
MCF
| $692K | ﹤0.01% |
151,425
+14,847
| +11% | +$56.5K |
|
|
KNTE
2403
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $690K | ﹤0.01% |
29,972
+14,517
| +94% | +$316K |
|
2404
Veritone
VERI
$122M
| $689K | ﹤0.01% |
28,849
+1,651
| +6% | +$33.7K |
|
2405
Procore
PCOR
$8.67B
| $688K | ﹤0.01% |
+7,703
| New | +$726K |
|
2406
Viking Therapeutics
VKTX
$4B
| $688K | ﹤0.01% |
109,528
+3,378
| +3% | +$20.9K |
|
2407
West Bancorporation
WTBA
$485M
| $686K | ﹤0.01% |
22,849
+680
| +3% | +$19.9K |
|
2408
Hingham Institution for Saving
HIFS
$663M
| $685K | ﹤0.01% |
2,034
+67
| +3% | +$20.9K |
|
2409
Equity Bancshares
EQBK
$1.05B
| $684K | ﹤0.01% |
20,485
+265
| +1% | +$8.28K |
|
|
LORL
2410
DELISTED
Loral Space and Communications, Inc.
LORL
| $681K | ﹤0.01% |
15,829
+600
| +4% | +$23.3K |
|
2411
Merchants Bancorp
MBIN
$2.49B
| $680K | ﹤0.01% |
25,829
+968
| +4% | +$24.1K |
|
|
GSKY
2412
DELISTED
GreenSky, Inc. Class A Common Stock
GSKY
| $679K | ﹤0.01% |
60,712
+3,125
| +5% | +$24.5K |
|
2413
TSMC
TSM
$2.18T
| $675K | ﹤0.01% |
+6,049
| New | +$710K |
|
|
BRY
2414
DELISTED
Berry Corp
BRY
| $674K | ﹤0.01% |
93,501
+2,676
| +3% | +$15.8K |
|
2415
Corsair Gaming
CRSR
$1.55B
| $674K | ﹤0.01% |
25,977
+703
| +3% | +$20.1K |
|
2416
Rigel Pharmaceuticals
RIGL
$750M
| $674K | ﹤0.01% |
18,576
+422
| +2% | +$16.6K |
|
|
PETQ
2417
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $673K | ﹤0.01% |
26,964
+1,250
| +5% | +$37.7K |
|
|
AUD
2418
DELISTED
Audacy, Inc.
AUD
| $672K | ﹤0.01% |
182,686
+4,930
| +3% | +$17.3K |
|
|
RDUS
2419
DELISTED
Radius Health, Inc.
RDUS
| $671K | ﹤0.01% |
54,039
+2,047
| +4% | +$29.5K |
|
2420
Regional Management Corp
RM
$303M
| $670K | ﹤0.01% |
11,519
+281
| +3% | +$15.5K |
|
2421
Axogen
AXGN
$2.5B
| $669K | ﹤0.01% |
42,327
+1,713
| +4% | +$30.8K |
|
|
BGFV
2422
DELISTED
Big 5 Sporting Goods
BGFV
| $668K | ﹤0.01% |
28,974
+539
| +2% | +$13.2K |
|
|
PTVE
2423
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
| $665K | ﹤0.01% |
53,093
+2,025
| +4% | +$27.5K |
|
2424
Entravision Communication
EVC
$1.1B
| $663K | ﹤0.01% |
93,383
+3,090
| +3% | +$20.9K |
|
2425
4D Molecular Therapeutics
FDMT
$562M
| $662K | ﹤0.01% |
24,538
+15,031
| +158% | +$429K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2021 Portfolio in Review
As of Q3 2021, RhumbLine Advisers held 3,088 positions worth $73.9B, down 3% from $76.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Trading was light in Q3 2021: portfolio turnover was 4.5%. RhumbLine Advisers opened 92 new positions and exited 46, leaving the 3,088-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q3 2021 buy was GXO Logistics: 250,722 shares worth $19.7M.
- RhumbLine Advisers added most to Moderna in Q3 2021, an estimated $60.7M increase.
- RhumbLine Advisers's biggest Q3 2021 reduction was Microsoft, cutting an estimated $89.3M.
- RhumbLine Advisers fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $77.4M.
- RhumbLine Advisers's ten largest holdings make up 23% of its $73.9B portfolio in Q3 2021.
- RhumbLine Advisers opened 92 new positions and closed 46 in Q3 2021.
- RhumbLine Advisers's portfolio value fell 3% quarter-over-quarter to $73.9B.
Based on RhumbLine Advisers's 13F filing for Q3 2021, filed 12 Nov 2021.